Our Latest News
Find our latest news below and follow us on our social media platforms.
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease
Cambridge, UK Wednesday 18th September 2024, 9AM GMT Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke cell-based assay developed by RxCelerate to test small molecules predicted to bind candidate target...
New Drosophila screening lab further expands RxCelerate’s drug discovery and development capabilities
Cambridge, UK Wednesday 24th April 2024, 9AM GMTRxCelerate is excited to launch our new fly screening service, further expanding the bespoke and flexible drug discovery and development services we offer. Cambridge, UK, 24 April 2024: The new lab offers cutting-edge...
RxCelerate acquires Methuselah Health and launches ProQuant™ world-beating proteomics service
Cambridge, UK and Cambridge, MA Tuesday 22nd November 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery company Methuselah Health UK Ltd for an undisclosed sum....
RxCelerate launch RxNfinity™: a next-generation machine learning-enabled small molecule discovery platform
Cambridge, UK and Cambridge, MA – Tuesday 19th July 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new small molecule discovery platform, RxNfinity™, that leverages machine learning,...
RxCelerate launch Galaxy™: a next-generation antibody discovery platform
Cambridge, UK and Cambridge, MA – Tuesday 16th February 2021, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new antibody discovery platform, Galaxy™, that offers significant advantages over...
RxCelerate expands space to 25,000 square feet
Cambridge, UK – January 23, 2020 BioMed Realty (“BioMed Realty” or the “Company”), a Blackstone portfolio company and a leading provider of real estate solutions to the life sciences community, and RxCelerate, one of the leading out-sourced drug discovery and...